The market moves on catalysts. Be first to know.

The acquisition aims to expand Vivakor's midstream operations.

Strategic move in the integrated freight and logistics sector.

The patent covers the company's noninvasive lung cancer detection technology.

The company filed a 6-K with the SEC.

Company announced its financial results for the first half of 2026.

Approval for testosterone replacement therapy.

The company has terminated its financing arrangement with Loci Capital.

Company expands into AI infrastructure and LLM services.

Company announced statistically significant results in metastatic prostate cancer treatment.

Additionally, Fortitude upsizes its DCG credit facility and available ZEC funding from DCG.